sglt2 inhibitors and glp 1 agonist 3. Integration of GLP-1RA or SGLT2i in Patients With T2D With or at Risk of atherosclerotic CVD How do SGLT-2 inhibitors, GLP-1

More recently, medications have been developed that act on both the GLP1 receptor and the GIP receptor (so theyre dual agonists)

2 Department of Internal Medicine, Lahore General Hospital, Ameer-Ud-Din Medical College, Lahore, Punjab, Pakistan Correspondence: Hongwei Jiang, Department of Metabolism and Endocrinology, Endocrine and Metabolic Disease Center, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Peoples Republic of China, Email [email protected] Abstract: Adolescent obesity is an escalating global health concern associated with increased risks of cardiovascular disease, type 2 diabetes mellitus, and long-term metabolic complications

Aug 22 2023;8(16)doi:10.1172/jci.insight.165944

Bannon, Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, United States Specialty section: This article was submitted to Cellular Neurophysiology, a section of the journal Frontiers in Cellular Neuroscience Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Liposomal delivery is the most effective way to ensure these nutrients are absorbed

The findings also indicate that improved communication strategies, particularly through patient interaction with a dietitian, could have an important role in supporting patients through these challenges by providing tailored advice on diet modifications and side effect management